LENZ
LENZ Therapeutics
LENZ
LENZ
62 hedge funds and large institutions have $72.9M invested in LENZ Therapeutics in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
24% less capital invested
Capital invested by funds: $95.4M → $72.9M (-$22.6M)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
Holders
62
Holding in Top 10
2
Calls
$1.46M
Puts
$1.47M
Top Buyers
| 1 | +$6.92M | |
| 2 | +$2.31M | |
| 3 | +$2.27M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.52M |
| 5 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$1.21M |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$3.71M | |
| 3 | -$2.32M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.59M |
| 5 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$847K |